Citations (146)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Thomas Greuter & Stephan R. Vavricka. (2019) Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis. Expert Review of Gastroenterology & Hepatology 13:4, pages 307-317.
Read now
Read now
Erik Schrumpf, Kirsten Muri Boberg & Tom H. Karlsen. (2015) Primary sclerosing cholangitis – the Norwegian experience. Scandinavian Journal of Gastroenterology 50:6, pages 781-796.
Read now
Read now
Lars Aabakken. (2015) Scandinavian journal of gastroenterology – the editors-in-chief. Scandinavian Journal of Gastroenterology 50:6, pages 630-635.
Read now
Read now
Emmanouil Sinakos & Keith Lindor. (2010) Treatment options for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 4:4, pages 473-488.
Read now
Read now
K. M. Boberg, K. E. A. Lundin & E. Schrumpf. (1994) Etiology and Pathogenesis in Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 29:sup204, pages 47-58.
Read now
Read now
V. Wewer, C. Gluud, P. Schlichting, F. Burcharth & V. Binder. (1991) Prevalence of Hepatobiliary Dysfunction in a Regional Group of Patients with Chronic Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 26:1, pages 97-102.
Read now
Read now
U. Broomé, H. Glaumann, R. Hultcrantz & U. Forsum. (1990) Distribution of HLA-DR, HLA-DP, HLA-DQ Antigens in Liver Tissue from Patients with Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 25:1, pages 54-58.
Read now
Read now
E. Aadland, E. Schrumpf, O. Fausa, K. Elgjo, A. Heilo, T. Aakhus & E. Gjone. (1987) Primary Sclerosing Cholangitis: A Long-Term Follow-up Study. Scandinavian Journal of Gastroenterology 22:6, pages 655-664.
Read now
Read now
Erik Schrumpf, Olav Fausa & Erling Aadland. (1987) Primary Sclerosing Cholangitis. Scandinavian Journal of Gastroenterology 22:6, pages 641-643.
Read now
Read now
B. Bosrkje, K. Vetvik, S. Osdegaard, E. Schrumpf, T. B. Larssen & F. Kolmannskog. (1985) Chronic Pancreatitis in Patients with Sclerosing Cholangitis and Ulcerative Colitis. Scandinavian Journal of Gastroenterology 20:4, pages 539-542.
Read now
Read now
L. Brinch, P. Teisberg, E. Schrumpf & I. Åkesson. (1982) The in Vivo Metabolism of C3 in Hepatobiliary Disease Associated with Ulcerative Colitis. Scandinavian Journal of Gastroenterology 17:4, pages 523-527.
Read now
Read now
Articles from other publishers (135)
You Sun Kim, Edward H. Hurley, Yoojeong Park & Sungjin Ko. (2023) Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis. Experimental & Molecular Medicine 55:7, pages 1380-1387.
Crossref
Crossref
Roger W. Chapman. (2022) Primary sclerosing cholangitis—A long night's journey into day. Clinical Liver Disease 20:S1, pages 21-32.
Crossref
Crossref
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani & Diego Vergani. (2022) HLA, gut microbiome and hepatic autoimmunity. Frontiers in Immunology 13.
Crossref
Crossref
David Ellinghaus. (2022) How genetic risk contributes to autoimmune liver disease. Seminars in Immunopathology 44:4, pages 397-410.
Crossref
Crossref
Teresa Da Cunha, Haleh Vaziri & George Y. Wu. (2022) Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review. Journal of Clinical and Translational Hepatology 10:3, pages 531-542.
Crossref
Crossref
Yanping Zheng, Ying Ran, Hongxia Zhang, Bangmao Wang & Lu Zhou. (2021) The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes. Frontiers in Physiology 12.
Crossref
Crossref
Georg Schneditz, Joshua E. Elias, Ester PaganoM. Zaeem Cader, Svetlana Saveljeva, Kathleen LongSubhankar MukhopadhyayMaryam ArastehTrevor D. LawleyGordon DouganAndrew Bassett, Tom H. KarlsenArthur Kaser & Nicole C. Kaneider. (2019) GPR35 promotes glycolysis, proliferation, and oncogenic signaling by engaging with the sodium potassium pump. Science Signaling 12:562.
Crossref
Crossref
Albert J. Czaja. 2019. Clinical Epidemiology of Chronic Liver Diseases. Clinical Epidemiology of Chronic Liver Diseases
251
305
.
David González-Serna, Martin Kerick & Javier Martín. 2019. Genetics of Rare Autoimmune Diseases. Genetics of Rare Autoimmune Diseases
163
182
.
Yuval A. Patel, Jacqueline B. Henson, Julius M. Wilder, Jiayin Zheng, Schein‐Chung Chow, Carl L. Berg, Stuart J. Knechtle & Andrew J. Muir. (2018) The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. Clinical Transplantation 32:10.
Crossref
Crossref
E. K. K. Henriksen, M. K. Viken, M. Wittig, K. Holm, T. Folseraas, S. Mucha, E. Melum, J. R. Hov, K. N. Lazaridis, B. D. Juran, O. Chazouillères, M. Färkkilä, D. N. Gotthardt, P. Invernizzi, M. Carbone, G. M. Hirschfield, S. M. Rushbrook, E. Goode, C. Y. Ponsioen, R. K. Weersma, B. Eksteen, K. K. Yimam, S. C. Gordon, D. Goldberg, L. Yu, C. L. Bowlus, A. Franke, B. A. Lie & T. H. Karlsen. (2017) HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry. HLA 90:4, pages 228-233.
Crossref
Crossref
Xiaojun Jiang & Tom H. Karlsen. (2017) Genetics of primary sclerosing cholangitis and pathophysiological implications. Nature Reviews Gastroenterology & Hepatology 14:5, pages 279-295.
Crossref
Crossref
Johannes R. Hov, Kirsten M. Boberg, Eli Taraldsrud, Mette Vesterhus, Maria Boyadzhieva, Inger Camilla Solberg, Erik Schrumpf, Morten H. Vatn, Benedicte A. Lie, Øyvind Molberg & Tom H. Karlsen. (2016) Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis. Liver International 37:3, pages 458-465.
Crossref
Crossref
Brian K. Chung & Gideon M. Hirschfield. (2017) Immunogenetics in primary sclerosing cholangitis. Current Opinion in Gastroenterology 33:2, pages 93-98.
Crossref
Crossref
James H. Tabibian, Konstantinos N. Lazaridis & Nicholas F. LaRusso. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
663
674.e5
.
Jayant A. Talwalkar & Konstantinos N. Lazaridis. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1835
1847
.
Tom H. Karlsen, Frank Lammert & Richard J. Thompson. (2015) Genetics of liver disease: From pathophysiology to clinical practice. Journal of Hepatology 62:1, pages S6-S14.
Crossref
Crossref
Sigrid Naess, Einar Björnsson, Jarl A. Anmarkrud, Said Al Mamari, Brian D. Juran, Konstantinos N. Lazaridis, Roger Chapman, Annika Bergquist, Espen Melum, Steven G. E. Marsh, Erik Schrumpf, Benedicte A. Lie, Kirsten M. Boberg, Tom H. Karlsen & Johannes R. Hov. (2014) Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease. Liver International 34:10, pages 1488-1495.
Crossref
Crossref
Randy S. Longman & Ellen J. Scherl. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
377
391
.
George F. Mells, Arthur Kaser & Tom H. Karlsen. (2013) Novel insights into autoimmune liver diseases provided by genome-wide association studies. Journal of Autoimmunity 46, pages 41-54.
Crossref
Crossref
Mohamad H. Imam, Jayant A. Talwalkar & Keith D. Lindor. (2013) Clinical management of autoimmune biliary diseases. Journal of Autoimmunity 46, pages 88-96.
Crossref
Crossref
Jimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, Eva Ellinghaus, Simon M Rushbrook, Nadezhda T Doncheva, Ole A Andreassen, Rinse K Weersma, Tobias J Weismüller, Bertus Eksteen, Pietro Invernizzi, Gideon M Hirschfield, Daniel Nils Gotthardt, Albert Pares, David Ellinghaus, Tejas Shah, Brian D Juran, Piotr Milkiewicz, Christian Rust, Christoph Schramm, Tobias Müller, Brijesh Srivastava, Georgios Dalekos, Markus M Nöthen, Stefan Herms, Juliane Winkelmann, Mitja Mitrovic, Felix Braun, Cyriel Y Ponsioen, Peter J P Croucher, Martina Sterneck, Andreas Teufel, Andrew L Mason, Janna Saarela, Virpi Leppa, Ruslan Dorfman, Domenico Alvaro, Annarosa Floreani, Suna Onengut-Gumuscu, Stephen S Rich, Wesley K Thompson, Andrew J Schork, Sigrid Næss, Ingo Thomsen, Gabriele Mayr, Inke R König, Kristian Hveem, Isabelle Cleynen, Javier Gutierrez-Achury, Isis Ricaño-Ponce, David van Heel, Einar Björnsson, Richard N Sandford, Peter R Durie, Espen Melum, Morten H Vatn, Mark S Silverberg, Richard H Duerr, Leonid Padyukov, Stephan Brand, Miquel Sans, Vito Annese, Jean-Paul Achkar, Kirsten Muri Boberg, Hanns-Ulrich Marschall, Olivier Chazouillères, Christopher L Bowlus, Cisca Wijmenga, Erik Schrumpf, Severine Vermeire, Mario Albrecht, John D Rioux, Graeme Alexander, Annika Bergquist, Judy Cho, Stefan Schreiber, Michael P Manns, Martti Färkkilä, Anders M Dale, Roger W Chapman, Konstantinos N Lazaridis, Andre Franke, Carl A Anderson & Tom H Karlsen. (2013) Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nature Genetics 45:6, pages 670-675.
Crossref
Crossref
Kirsten Boonstra, Karel J. van Erpecum, Karin M.J. van Nieuwkerk, Joost P.H. Drenth, Alexander C. Poen, Ben J.M. Witteman, Hans A.R.E. Tuynman, Ulrich Beuers & Cyriel Y. Ponsioen. (2012) Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflammatory Bowel Diseases 18:12, pages 2270-2276.
Crossref
Crossref
Sigrid Næss, Alexey Shiryaev, Johannes R. Hov, Andre Franke & Tom H. Karlsen. (2012) Genetics in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology 36:4, pages 325-333.
Crossref
Crossref
Douglas L. Nguyen, Nicholas F. LaRusso & Konstantinos N. Lazaridis. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
603
614.e3
.
Tom H. Karlsen, Kirsten Muri Boberg & Erik Schrumpf. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
754
781
.
Alberto Quaglia, Alastair D. Burt, Linda D. Ferrell & Bernard C. Portmann. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
935
986
.
Marion J. Pollheimer, Emina Halilbasic, Peter Fickert & Michael Trauner. (2011) Pathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 25:6, pages 727-739.
Crossref
Crossref
Trine Folseraas, Espen Melum, Andre Franke & Tom H. Karlsen. (2011) Genetics in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 25:6, pages 713-726.
Crossref
Crossref
Laetitia E. Lamberts, Marcel Janse, Elizabeth B. Haagsma, Arie P. van den Berg & Rinse K. Weersma. (2011) Immune-mediated diseases in primary sclerosing cholangitis. Digestive and Liver Disease 43:10, pages 802-806.
Crossref
Crossref
Christopher L. Bowlus. (2010) Cutting Edge Issues in Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 41:2, pages 139-150.
Crossref
Crossref
Peter T. Donaldson. (2011) Electrostatic modifications of the human leukocyte antigen DR P9 peptide‐binding pocket in primary sclerosing cholangitis: Back to the future with human leukocyte antigen DRβ. Hepatology 53:6, pages 1798-1800.
Crossref
Crossref
Marcel Janse, Laetitia E. Lamberts, Lude Franke, Soumya Raychaudhuri, Eva Ellinghaus, Kirsten Muri Boberg, Espen Melum, Trine Folseraas, Erik Schrumpf, Annika Bergquist, Einar Björnsson, Jingyuan Fu, Harm Jan Westra, Harry J.M. Groen, Rudolf S.N. Fehrmann, Joanna Smolonska, Leonard H. van den Berg, Roel A. Ophoff, Robert J. Porte, Tobias J. Weismüller, Jochen Wedemeyer, Christoph Schramm, Martina Sterneck, Rainer Günther, Felix Braun, Severine Vermeire, Liesbet Henckaerts, Cisca Wijmenga, Cyriel Y. Ponsioen, Stefan Schreiber, Tom H. Karlsen, Andre Franke & Rinse K. Weersma. (2011)
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for
IL2, REL
, and
CARD9
. Hepatology 53:6, pages 1977-1985.
Crossref
Crossref
Johannes R. Hov, Vasilis Kosmoliaptsis, James A. Traherne, Marita Olsson, Kirsten M. Boberg, Annika Bergquist, Erik Schrumpf, J. Andrew Bradley, Craig J. Taylor, Benedicte A. Lie, John Trowsdale & Tom H. Karlsen. (2011) Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 53:6, pages 1967-1976.
Crossref
Crossref
Marina G. Silveira & Keith D. Lindor. 2011. Molecular Pathology of Liver Diseases. Molecular Pathology of Liver Diseases
741
752
.
Christopher L. Bowlus, Chin-Shang Li, Tom H. Karlsen, Benedicte A. Lie & Carlo Selmi. (2010) Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: Unique clinical and human leukocyte antigen associations. Liver Transplantation 16:11, pages 1324-1330.
Crossref
Crossref
Nishchay Chandra, Susan N Cullen & Roger W Chapman. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
533
553
.
Tom H. Karlsen, Erik Schrumpf & Kirsten M. Boberg. (2010) Update on primary sclerosing cholangitis. Digestive and Liver Disease 42:6, pages 390-400.
Crossref
Crossref
Johannes R. Hov, Ana Lleo, Carlo Selmi, Bente Woldseth, Luca Fabris, Mario Strazzabosco, Tom H. Karlsen & Pietro Invernizzi. (2010) Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-C. Journal of Hepatology 52:5, pages 712-717.
Crossref
Crossref
Tom H. Karlsen, Andre Franke, Espen Melum, Arthur Kaser, Johannes Roksund Hov, Tobias Balschun, Benedicte A. Lie, Annika Bergquist, Christoph Schramm, Tobias J. Weismüller, Daniel Gotthardt, Christian Rust, Eva E.R. Philipp, Teresa Fritz, Liesbet Henckaerts, Rinse K. Weersma, Pieter Stokkers, Cyriel Y. Ponsioen, Cisca Wijmenga, Martina Sterneck, Michael Nothnagel, Jochen Hampe, Andreas Teufel, Heiko Runz, Philip Rosenstiel, Adolf Stiehl, Severine Vermeire, Ulrich Beuers, Michael P. Manns, Erik Schrumpf, Kirsten Muri Boberg & Stefan Schreiber. (2010) Genome-Wide Association Analysis in Primary Sclerosing Cholangitis. Gastroenterology 138:3, pages 1102-1111.
Crossref
Crossref
Andrew S. Ross & Kris V. Kowdley. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
1153
1170.e6
.
Edward Biobele Alabraba, Darius Mirza & James Neuberger. (2009) Reply: The urgent need for evaluating recurrent primary sclerosing cholangitis in living donor liver transplantation. Liver Transplantation 15:10, pages 1385-1385.
Crossref
Crossref
Jonathan H. Aron & Christopher L. Bowlus. (2009) The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 31:3, pages 383-397.
Crossref
Crossref
Edward Alabraba, Peter Nightingale, Bridget Gunson, Stefan Hubscher, Simon Olliff, Darius Mirza & James Neuberger. (2009) A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transplantation 15:3, pages 330-340.
Crossref
Crossref
Andrea Cassinotti, Sarah Birindelli, Mario Clerici, Daria Trabattoni, Marco Lazzaroni, Sandro Ardizzone, Riccardo Colombo, Edoardo Rossi & Gabriele Bianchi Porro. (2008) HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists. The American Journal of Gastroenterology 104:1, pages 195-217.
Crossref
Crossref
Ali Shorbagi & Yusuf Bayraktar. (2008) Primary sclerosing cholangitis - What is the difference between east and west?. World Journal of Gastroenterology 14:25, pages 3974.
Crossref
Crossref
Roger Chapman & Sue Cullen. (2008) Etiopathogenesis of primary sclerosing cholangitis. World Journal of Gastroenterology 14:21, pages 3350.
Crossref
Crossref
Roger Chapman. 2008. Digestive Involvement in Systemic Autoimmune Diseases. Digestive Involvement in Systemic Autoimmune Diseases
169
188
.
Espen Melum, Tom H. Karlsen, Erik Schrumpf, Annika Bergquist, Erik Thorsby, Kirsten M. Boberg & Benedicte A. Lie. (2007) Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms. Hepatology 47:1, pages 90-96.
Crossref
Crossref
Tom H. Karlsen, Kirsten Muri Boberg, Marita Olsson, Ji-Yao Sun, David Senitzer, Annika Bergquist, Erik Schrumpf, Erik Thorsby & Benedicte A. Lie. (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. Journal of Hepatology 46:5, pages 899-906.
Crossref
Crossref
Irma Matinlauri, Markku Nurminen, Krister Höckerstedt & Helena Isoniemi. (2007) Human leukocyte antigen associations in Finnish liver transplantations due to primary sclerosing cholangitis and primary biliary cirrhosis. Open Medicine 2:1, pages 12-25.
Crossref
Crossref
K. Wiencke, T. H. Karlsen, K. M. Boberg, E. Thorsby, E. Schrumpf, B. A. Lie & A. Spurkland. (2007) Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. Tissue Antigens 69:2, pages 161-169.
Crossref
Crossref
A.J. SMALL, N.F. LARUSSO & K.N. LAZARIDIS. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
613
627
.
Christopher L. Bowlus, Tom H. Karlsen, Ulrika Broomé, Erik Thorsby, Morten Vatn, Erik Schrumpf, Benedicte A. Lie & Kirsten Muri Boberg. (2006) Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. Journal of Hepatology 45:5, pages 704-710.
Crossref
Crossref
Robert Enns. 2006. Diseases of the Gallbladder and Bile Ducts. Diseases of the Gallbladder and Bile Ducts
306
331
.
DIEGO VERGANI & GIORGINA MIELI-VERGANI. 2006. The Autoimmune Diseases. The Autoimmune Diseases
767
777
.
C Miki, J D Harrison, B K Gunson, J A C Buckels, P McMaster & A D Mayer. (1995) Inflammatory bowel disease in primary sclerosing cholangitis: An analysis of patients undergoing liver transplantation. British Journal of Surgery 82:8, pages 1114-1117.
Crossref
Crossref
Hidekazu Inoue, Katsuya Shiraki, Hiroshi Okano, Masatoshi Deguchi, Takenari Yamanaka, Takahisa Sakai, Shigeru Ohmori, Hitoshi Yoshimura & Takeshi Nakano. (2005) Acute Pancreatitis in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 50:6, pages 1064-1067.
Crossref
Crossref
Piero Portincasa. (2005) Primary sclerosing cholangitis: Updates in diagnosis and therapy. World Journal of Gastroenterology 11:1, pages 7.
Crossref
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2005) Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 11:1, pages 62-72.
Crossref
Crossref
Sue Cullen & Roger Chapman. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
731
745
.
Roger Chapman & Sue Cullen. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
435
451
.
Kristine Wiencke, Andrew Sverre Louka, Anne Spurkland, Morten Vatn, the IBSEN study group, Erik Schrumpf & Kirsten Muri Boberg. (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. Journal of Hepatology 41:2, pages 209-214.
Crossref
Crossref
Flavia D Mendes & Keith D Lindor. (2004) Primary sclerosing cholangitis. Clinics in Liver Disease 8:1, pages 195-211.
Crossref
Crossref
Sue Cullen & Roger Chapman. (2003) Primary sclerosing cholangitis. Autoimmunity Reviews 2:6, pages 305-312.
Crossref
Crossref
Sue Cullen & Roger Chapman. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
731
745
.
Cyriel Y. Ponsioen, Pieter C.F. Stokkers, Ann R. vd Horst, Guido N.J. Tytgat & Sander J.H. van Deventer. (2001) A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects. European Journal of Internal Medicine 12:6, pages 518-521.
Crossref
Crossref
Raymond T. Chung & Eric C. Sheffer. (2001) Case 28-2001. New England Journal of Medicine 345:11, pages 817-823.
Crossref
Crossref
Peter T. Donaldson & Suzanne Norris. (2001) Immunogenetics in PSC. Best Practice & Research Clinical Gastroenterology 15:4, pages 611-627.
Crossref
Crossref
Sue Cullen & Roger Chapman. (2001) Aetiopathogenesis of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 577-589.
Crossref
Crossref
Suzanne Norris, Elli Kondeatis, Robert Collins, Henry Stephens, Phillip Harrison, Robert Vaughan, Mike Clare, Jack Satsangi, Roger Chapman & Peter Donaldson. (2001) Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: The role of MICA polymorphism. Gastroenterology 120:6, pages 1475-1482.
Crossref
Crossref
S. Saarinen, O. Olerup & U. Broome. (2000) Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. The American Journal of Gastroenterology 95:11, pages 3195-3199.
Crossref
Crossref
Jayant A. Talwalkar, Nicholas F. LaRusso & Keith D. Lindor. (2000) Defining the relationship between autoimmune disease and primary sclerosing cholangitis. The American Journal of Gastroenterology 95:11, pages 3024-3026.
Crossref
Crossref
peter t donaldson, suzanne norris, patrizia k constantini, will bernal, phillip harrison & roger williams. (2000) the interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. Journal of Hepatology 32:6, pages 882-886.
Crossref
Crossref
Ludvig M. Sollid, A. Spurkland & Erik Thorsby. 2000. HLA in Health and Disease. HLA in Health and Disease
249
262
.
P. T. Donaldson. 2000. Immunology and Liver. Immunology and Liver
115
132
.
Vivek Raj & David R. Lichtenstein. (1999) HEPATOBILIARY MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 491-513.
Crossref
Crossref
A. Spurkland, S. Saarinen, K.M. Boberg, S. Mitchell, U. Broome, L. Caballeria, E. Ciusani, R. Chapman, G. Ercilla, O. Fausa, I. Knutsen, A. Pares, F. Rosina, O. Olerup, E. Thorsby & E. Schrumpf. (1999) HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:5, pages 459-469.
Crossref
Crossref
José Franco & Kia Saeian. (1999) Biliary tract inflammatory disorders: Primary sclerosing cholangitis and primary biliary cirrhosis. Current Gastroenterology Reports 1:2, pages 95-101.
Crossref
Crossref
William Bernal, Manus Moloney, James Underhill & Peter T Donaldson. (1999) Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. Journal of Hepatology 30:2, pages 237-241.
Crossref
Crossref
Caroline Roozendaal, A.W.Marc Van Milligen de Wit, Els B. Haagsma, Gerda Horst, Carolynne Schwarze, Hans H. Peter, Jan H. Kleibeuker, Jan W.Cohen Tervaert, Pieter C. Limburg & Cees G.M. Kallenberg. (1998) Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. The American Journal of Medicine 105:5, pages 393-399.
Crossref
Crossref
Manus M. Moloney, Linda J. Thomson, Michael J. Strettell, Roger Williams & Peter T. Donaldson. (1998) Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis. Hepatology 28:3, pages 660-662.
Crossref
Crossref
George V Papatheodoridis, Mark Hamilton, Keith Rolles & Andrew K Burroughs. (1998) Liver transplantation and inflammatory bowel disease. Journal of Hepatology 28:6, pages 1070-1076.
Crossref
Crossref
Cyriel IJ Ponsioen & Guido N J Tytgat. (1998) Primary Sclerosing Cholangitis: A Clinical Review. American Journal of Gastroenterology 93:4, pages 515-523.
Crossref
Crossref
Karin Lundqvist & Ulrika Broomé. (1997) Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis. Diseases of the Colon & Rectum 40:4, pages 451-456.
Crossref
Crossref
Edward V. LoftusJr.Jr., William J. Sandborn, Keith D. Lindor & Nicholas F. LaRusso. (1997) Interactions Between Chronic Liver Disease and Inflammatory Bowel Disease. Inflammatory Bowel Diseases 3:4, pages 288-302.
Crossref
Crossref
Steven A. Ahrendt & Henry A. Pitt. (1996) Sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Surgery 3:4, pages 431-441.
Crossref
Crossref
Frank Seibold, Rüdiger Klein & &NA; Jakob. (1996) Polymyositis, Alopecia Universalis, and Primary Sclerosing Cholangitis in a Patient with Crohn's Disease. Journal of Clinical Gastroenterology 23:2, pages 121-124.
Crossref
Crossref
Mitsuro Chiba, Fumio Tobori, Hitoshi Yagisawa, Masafumi Komatsu, Okitaka Maie & Osamu Masamune. (1996) A Japanese Case of Ulcerative Colitis Associated with Dermatitis Herpetiformis and Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2:4, pages 255-259.
Crossref
Crossref
Michael Wilschanski, Peter Chait, Judy A. Wade, Lori Davis, Mary Corey, Patrick St. Louis, Anne M. Griffiths, Laurence M. Blendis, Stanley P. Moroz, Linda Scully & Eve A. Roberts. (1995) Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis. Hepatology 22:5, pages 1415-1422.
Crossref
Crossref
Vijayan Balan & Nicholas F. LaRusso. (1995) HEPATOBILIARY DISEASE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 24:3, pages 647-669.
Crossref
Crossref
Shunji Narumi, John P. Roberts, Jean C. Emond, John Lake & Nancy L. Ascher. (1995) Liver transplantation for sclerosing cholangitis. Hepatology 22:2, pages 451-457.
Crossref
Crossref
Young-Mee Lee & Marshall M. Kaplan. (1995) Primary Sclerosing Cholangitis. New England Journal of Medicine 332:14, pages 924-933.
Crossref
Crossref
S Bloom, K Fleming & R Chapman. (1995) Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.. Gut 36:4, pages 604-609.
Crossref
Crossref
James A. Underhill, Peter T. Donaldson, Derek G. Doherty, Koji Manabe & Roger Williams. (1995) HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis. Hepatology 21:4, pages 959-962.
Crossref
Crossref
MARJUT H. K. LEIDENIUS, SAIJA A. KOSKIMIES, ILMO H. KELLOKUMPU & KRISTER A. V. HÖCKERSTEDT. (2009) HLA antigens in ulcerative colitis and primary sclerosing cholangitis. APMIS 103:7-8, pages 519-524.
Crossref
Crossref
Roger Chapman. (1995) Does HLA status influence prognosis in primary sclerosing cholangitis?. Gastroenterology 108:3, pages 937-940.
Crossref
Crossref
Olle Olerup, Rolf Olsson, Rolf Hultcrantz & Ulrika Broome. (1995) HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 108:3, pages 870-878.
Crossref
Crossref
Alex Harmatz. (1994) Hepatobiliary manifestations of inflammatory bowel disease. Medical Clinics of North America 78:6, pages 1387-1398.
Crossref
Crossref
Yoshiyuki Ueno & Nicholas F. LaRusso. (1994) Primary sclerosing cholangitis. Journal of Gastroenterology 29:4, pages 531-543.
Crossref
Crossref
Peter Donaldson, Derek Doherty, James Underhill & Roger Williams. (1994) The molecular genetics of autoimmune liver disease. Hepatology 20:1, pages 225-239.
Crossref
Crossref
Michael P. Manns & Martin Krüger. (1994) Immunogenetics of chronic liver diseases. Gastroenterology 106:6, pages 1676-1697.
Crossref
Crossref
Su K. Lo, Kenneth A. Fleming & Roger W. Chapman. (1994) A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment. Journal of Hepatology 21:6, pages 974-978.
Crossref
Crossref
Wajahat Z. Mehal, Y.-M. Dennis Lo, B. Paul Wordsworth, James M. Neuberger, Stefan C. Hubscher, Kenneth A. Fleming & Roger W. Chapman. (1994) HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 106:1, pages 160-167.
Crossref
Crossref
R. W. Chapman. 1994. Immunology of Liver Disease. Immunology of Liver Disease
145
155
.
Kevin M. Man, Anne Drejet, Emmet B. Keeffe, Richard Garcia-Kennedy, Joanne C. Imperial & Carlos O. Esquivel. (1993) Primary sclerosing cholangitis and Hodgkin's disease. Hepatology 18:5, pages 1127-1131.
Crossref
Crossref
O. Eilam, E. Goldin, D. Shouval, T. Gimon & C. Brautbar. (1993) Sclerosing cholangitis associated with Crohn's disease and autoimmune haemolytic anaemia.. Postgraduate Medical Journal 69:814, pages 656-658.
Crossref
Crossref
S K Lo, R W Chapman & K A Fleming. (1993) Tissue distribution of autoantigen specific for primary sclerosing cholangitis.. Journal of Clinical Pathology 46:3, pages 246-249.
Crossref
Crossref
S.‐A. IVARSSON, S. ERIKSSON, I. KOCKUM, Å. LERNMARK, S. LINDGREN, K. O. NILSSON, G. SUNDKVIST & R. WASSMUTH. (2009) HLA‐DR3, DQ2 homozygosity in two patients with insulin‐dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis. Journal of Internal Medicine 233:3, pages 281-286.
Crossref
Crossref
A. Amar, C. Brautbar, E. Goldin, L. Sherman, S. Barmeir, D. Shouval, J. A. Hansen & A. G. Smith. (2007) SEROLOGICAL AND MOLECULAR ANALYSIS OF HLA IN ISRAELI PRIMARY SCLEROSING CHOLANGITIS PATIENTS. International Journal of Immunogenetics 19:5, pages 295-302.
Crossref
Crossref
J. Mark Farrant, Derek G. Doherty, Peter T. Donaldson, Robert W. Vaughan, Karen M. Hayllar, Ken I. Welsh, Adrian L. W. F. Eddleston & Roger Williams. (1992) Amino acid substitutions at position 38 of the DRβ polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 16:2, pages 390-395.
Crossref
Crossref
Rui Perdigoto, Herschel A. Carpenter & Albert J. Czaja. (1992) Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. Journal of Hepatology 14:2-3, pages 325-331.
Crossref
Crossref
R W Chapman. (1991) Aetiology and natural history of primary sclerosing cholangitis--a decade of progress?. Gut 32:12, pages 1433-1435.
Crossref
Crossref
. (1991) Inability to Attribute Susceptibility to Primary Sclerosing Cholangitis to Specific Amino Acid Positions of the HLA-DRw52a Allele. New England Journal of Medicine 325:17, pages 1251-1252.
Crossref
Crossref
Alan E. Kilby, Edward L. Krawitt, Richard J. Albertini, Bettejayne F. Chastenay & Alex John. (1991) Suppressor T-cell deficiency in primary sclerosing cholangitis. Digestive Diseases and Sciences 36:9, pages 1213-1216.
Crossref
Crossref
N. Grunnet, H. H. Rasmussen, U. Tage‐Jensen & S. Nørby Rasmussen. (2008) Association of primary sclerosing cholangitis with HLA‐DRw52a?. Tissue Antigens 38:1, pages 133-136.
Crossref
Crossref
G. P. Ramelli, O. Tönz, A. Zimmermann & M. J. Lentze. (1991) Crohn disease with sclerosing cholangitis and liver cirrhosis in adolescence. European Journal of Pediatrics 150:8, pages 557-559.
Crossref
Crossref
Peter T. Donaldson, J. Mark Farrant, Mark L. Wilkinson, Karen Hayllar, Bernard C. Portmann & Roger Williams. (1991) Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis. Hepatology 13:1, pages 129-133.
Crossref
Crossref
Keith D. Lindor, Russell H. Wiesner, Robert L. MacCarty, Jurgen Ludwig & Nicholas F. Larusso. (1990) Advances in primary sclerosing cholongitis. The American Journal of Medicine 89:1, pages 73-80.
Crossref
Crossref
Ernest J. Prochazka, Paul I. Terasaki, Min Sik Park, Leonard I. Goldstein & Ronald W. Busuttil. (1990) Association of Primary Sclerosing Cholangitis with HLA-DRw52a. New England Journal of Medicine 322:26, pages 1842-1844.
Crossref
Crossref
S. Magrin, K.T. Nouri-Aria, P.T. Donaldson, M.L. Wilkinson, B.C. Portmann, Roger Williams & A.L.W.F. Eddleston. (1989) The relationship between HLA-DR3 and T-cell regulation of immunoglobulin production in primary sclerosing cholangitis. Clinical Immunology and Immunopathology 50:2, pages 205-212.
Crossref
Crossref
LENE O. POULSEN, LEIF FREUND, KIRSTEN LYLLOFF & NIELS GRUNNET. (2009) Positive Coombs' Test Associated with Ulcerative Colitis. Acta Medica Scandinavica 223:1, pages 75-78.
Crossref
Crossref
Robert J. L. Anderson, Philip A. Dyer, Dian Donnai, Peter T. Klouda, Roland Jennison & Joan M. Braganza. (1988) Chronic pancreatitis, HLA and autoimmunity. International journal of pancreatology 3:1, pages 83-90.
Crossref
Crossref
H.J.F. Hodgson & D.P. Jewell. (1987) 4 Immunology of inflammatory bowel disease. Baillière's Clinical Gastroenterology 1:3, pages 531-545.
Crossref
Crossref
Keith D. Lindor, Russell H. Wiesner, Jerry A. Katzmann, Nicholas F. Larusso & Sandra J. Beaver. (1987) Lymphocyte subsets in primary sclerosing cholangitis. Digestive Diseases and Sciences 32:7, pages 720-725.
Crossref
Crossref
Seid Hossein Mir-Madjlessi, Richard G. Farmer & Michael V. SivakJrJr. (1987) Bile duct carcinoma in patients with ulcerative colitis. Digestive Diseases and Sciences 32:2, pages 145-154.
Crossref
Crossref
Susan M. Williams & Roger K. Harned. (1987) Hepatobiliary Complications of Inflammatory Bowel Disease. Radiologic Clinics of North America 25:1, pages 175-188.
Crossref
Crossref
Calogero Caruso, Patrizia Palmeri, Lorenzo Oliva, Ambrogio Orlando & Mario Cottone. (2008) HLA antigens in ulcerative colitis: a study in the Sicilian population. Tissue Antigens 25:1, pages 47-49.
Crossref
Crossref
F. Warwick, R.J.L. Anderson & J.M. Braganza. (1985) Sclerosing-cholangitis-like changes in pancreatic disease. Clinical Radiology 36:1, pages 51-56.
Crossref
Crossref
I.G. McFarlane. (1985) Autoreactivity against biliary tract antigens in primary biliary cirrhosis. Molecular Aspects of Medicine 8:3, pages 249-267.
Crossref
Crossref
Jawahar L. Tiwari & Paul I. TerasakiJawahar L. Tiwari & Paul I. Terasaki. 1985. HLA and Disease Associations. HLA and Disease Associations
232
263
.
. (2022) Letters to the Editor. Journal of the Royal Society of Medicine 77:1, pages 84-85.
Crossref
Crossref
W. Küster & W. Lenz. 1984. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics
103
132
.
E. Rolland Dickson, Nicholas F. Larusso & Russell H. Wiesner. (1984) Primary Sclerosing Cholangitis. Hepatology 4:S1, pages 33S-35S.
Crossref
Crossref
E.M.M. Quigley, N.F. LaRusso, J. Ludwig, R.N.M. MacSween, G.G. Birnie & G. Watkinson. (1983) Familial Occurrence of Primary Sclerosing Cholangitis and Ulcerative Colitis. Gastroenterology 85:5, pages 1160-1165.
Crossref
Crossref